InterPAD - DETAILS

glyburide, Glibenclamide, 10238-21-8, Glybenclamide, Glynase, Diabeta, Micronase, Euglucon, Daonil, Glybenzcyclamide, Semi-daonil, Apo-Glibenclamide, Azuglucon, Bastiverit, Benclamin, Betanase, Duraglucon, Euglucan, Euglykon, Glibenil, Glucolon, Orabetic, Prodiabet, Renabetic, Yuglucon, Dibelet, Gilemal, Glibens, Glibil, Glimel, Glimide, Humedia, Libanil, Maninil, Suraben, Tiabet, Adiab, Melix, Pira, Med-Glionil, Euglucon 5, Glibenclamidum, Calabren, Euclamin, Gewaglucon, Glibenbeta, Glibesyn, Glibetic, Gliboral, Glidiabet, Glisulin, Glitisol, Glucobene, Glucohexal, Glucomid, Glucoremed, Glucoven, Glycomin, Hexaglucon, Lederglib, Lisaglucon, Miglucan, Normoglucon, Praeciglucon, Cytagon, Debtan, Glamide, Gliban, Gliben, Glibet, Glicem, Gluben, Glyben, Sugril, Nadib, Novo-Glyburide, Glibenclamid AL, Gen-Glybe, Norglicem 5, Betanese 5, Glibenclamid Fabra, Glibenclamida, Glibenclamid Basics, Glibenclamid-Cophar, Glibenclamid Heumann, Semi-Euglucon, Hemi-Daonil, Glibenclamid Genericon, Glibenclamid-Ratiopharm, 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide, Semi-Gliben-Puren N, Glibenclamid Riker M., HB 419, Glibenclamidum [INN-Latin], Glyburide (micronized), GBN 5, Glibenclamida [INN-Spanish], Micronized glyburide, UR 606, glyburide (glibenclamide), 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea, 1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea, HB-419, Amglidia, Cirara, UNII-SX6K58TVWC, U 26452, SX6K58TVWC, 5-Chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide, EINECS 233-570-6, NSC-759618, Neogluconin, BRN 2230085, CHEBI:5441, 5-chloro-N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-2-methoxybenzamide, Glibenclamide [INN], 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide, Glyburide [USAN:USP], N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea, Benzamide, 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-, Glubate, MFCD00056625, CHEMBL472, U-26452, RP-1127, 5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide, U-26,452, Urea, 1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexyl-, MLS000069721, DTXSID0037237, U-26,45, Urea, 1-((p-(2-(chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl-, GLUCOVANCE COMPONENT GLYBURIDE, Benzamide, 5-chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxy-, N-(4-(beta-(2-Methoxy-5-chlorbenzamido)-aethyl)-benzolsulfonyl)-N'-cyclohexyl-harnstoff, NSC 759618, Glyburide [USAN], NCGC00015467-11, Abbenclamide, Diabiphage, Glibadone, SMR000058229, Glyburide (USAN:USP), C23H28ClN3O5S, CAS-10238-21-8, N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea, GLYBURIDE (USP-RS), GLYBURIDE [USP-RS], Glibenclamidum (INN-Latin), 5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide, 5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]-amino]sulfonyl]phenyl]-ethyl]-2-methoxybenzamide, Glibenclamida (INN-Spanish), GLIBENCLAMIDE (MART.), GLIBENCLAMIDE [MART.], DTXCID8017237, GLYBURIDE (USP MONOGRAPH), GLYBURIDE [USP MONOGRAPH], Glycron, GLIBENCLAMIDE (EP MONOGRAPH), GLIBENCLAMIDE [EP MONOGRAPH], 1-[[p-[2-(5-Chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohexylurea, 5-chloro-N-(2-{4-[N-(N-cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide, Glyburide (USP), Micronase (TN), 1-{4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonyl}-3-cyclohexylurea;1-{4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonyl}-3-cyclohexylurea, Diabeta (TN), Glynase (TN), SR-01000000196, Delmide, 5-chloro-N-(2-(4-(N-(N-cyclohexylcarbamoyl)sulfamoyl)phenyl)ethyl)-2-methoxybenzamide, 5-chloro-N-(4-[N-(cyclohexylcarbamoyl)sulfamoyl]phenethyl)-2-methoxybenzamide, Glibenclamide,(S), GBM, Prestwick_569, Spectrum_000250, Tocris-0911, Glibenclamide - Bio-X, Glybenzcyclamide, 99%, Glibenclamide; Glyburide, Opera_ID_801, GLYBURIDE [MI], Prestwick0_000316, Prestwick1_000316, Prestwick2_000316, Prestwick3_000316, Spectrum2_001816, Spectrum3_001327, Spectrum4_001199, Spectrum5_001631, GLYBURIDE [VANDF], Lopac-G-0639, Probes1_000431, Probes2_000378, UPCMLD-DP006, G 0639, GLIBENCLAMIDE [JAN], GLYBURIDE [WHO-IP], Glibenclamide (JP17/INN), CBiol_001790, Lopac0_000499, Oprea1_764617, SCHEMBL22009, BSPBio_000312, BSPBio_001351, BSPBio_003053, KBioGR_000071, KBioGR_001897, KBioSS_000071, KBioSS_000730, MLS001077262, BIDD:GT0239, DivK1c_000481, SPECTRUM2300229, SPBio_001831, SPBio_002531, GLIBENCLAMIDE [WHO-DD], GLIBENCLAMIDE [WHO-IP], BPBio1_000344, GTPL2414, GLYBURIDE [ORANGE BOOK], UPCMLD-DP006:001, HMS501I03, KBio1_000481, KBio2_000071, KBio2_000730, KBio2_002639, KBio2_003298, KBio2_005207, KBio2_005866, KBio3_000141, KBio3_000142, KBio3_002273, A10BB01, Glybenclamide, >=99% (HPLC), NINDS_000481, Bio1_000076, Bio1_000565, Bio1_001054, Bio2_000071, Bio2_000551, HMS1361D13, HMS1568P14, HMS1791D13, HMS1922L08, HMS1989D13, HMS2089L06, HMS2093P04, HMS2095P14, HMS3259O12, HMS3261D19, HMS3267A15, HMS3402D13, HMS3411F16, HMS3428D15, HMS3651E17, HMS3675F16, HMS3712P14, Pharmakon1600-02300229, BCP05327, Glibenclamide for peak identification, Tox21_110158, Tox21_300758, Tox21_500499, BDBM50012957, CCG-39618, HD 419, NSC759618, NSC813214, STK362992, GLIBENCLAMIDUM [WHO-IP LATIN], Glyburide - CAS 10238-21-8, AKOS001487495, Tox21_110158_1, BCP9000729, CS-1075, DB01016, KS-5326, LP00499, NC00566, NSC-813214, SB17414, SDCCGSBI-0050483.P004, 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)-phenethyl)-2-methoxybenzamide, GLYBURIDE COMPONENT OF GLUCOVANCE, IDI1_000481, IDI1_033821, Glibenclamide 1.0 mg/ml in Acetonitrile, NCGC00015467-01, NCGC00015467-02, NCGC00015467-03, NCGC00015467-04, NCGC00015467-05, NCGC00015467-06, NCGC00015467-07, NCGC00015467-08, NCGC00015467-09, NCGC00015467-10, NCGC00015467-12, NCGC00015467-13, NCGC00015467-14, NCGC00015467-15, NCGC00015467-16, NCGC00015467-17, NCGC00015467-18, NCGC00015467-20, NCGC00015467-21, NCGC00015467-36, NCGC00015467-37, NCGC00016689-01, NCGC00023447-02, NCGC00023447-04, NCGC00023447-05, NCGC00023447-06, NCGC00023447-07, NCGC00023447-08, NCGC00023447-09, NCGC00023447-10, NCGC00023447-11, NCGC00023447-12, NCGC00254662-01, NCGC00261184-01, BG166164, HY-15206, SY057080, SBI-0050483.P003, Glyburide, meets USP testing specifications, AB00051949, EU-0100499, FT-0601608, G0382, NS00001144, S1716, SW195828-5, A19539, C07022, D00336, D81733, EN300-117270, M01823, AB00051949-16, AB00051949-17, AB00051949_18, AB00051949_19, Q420626, SR-01000000196-2, SR-01000000196-4, SR-01000000196-5, SR-01000000196-6, SR-01000000196-8, W-108874, BRD-K36927236-001-06-0, BRD-K36927236-001-17-7, Z277540138, Glybenclamide, European Pharmacopoeia (EP) Reference Standard, Glyburide, United States Pharmacopeia (USP) Reference Standard, 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl urea, 5-Chloro-N-[4-(3-cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide, 4-(2-(5-Chloro-2-methoxybenzoylamino)ethyl)-N-(cyclohexylcarbamoyl)benzenesulfonamide, Glibenclamide for peak identification, European Pharmacopoeia (EP) Reference Standard, Glyburide (Glibenclamide), Pharmaceutical Secondary Standard; Certified Reference Material, N-(4-(.beta.-(2-Methoxy-5-chlorbenzamido)-aethyl)-benzolsulfonyl)-N'-cyclohexyl-harnstoff, N1-[4-({[(cyclohexylamino)carbonyl]amino}sulfonyl)phenethyl]-5-chloro-2-methoxybenzamide, 5-Chloro-N-(2-[4-(([(cyclohexylamino)carbonyl]amino)sulfonyl)phenyl]ethyl)-2-methoxybenzamide #

Name	Glyburide
PubChem CID	3488
Molecular Weight	494.0g/mol
Synonyms	glyburide, Glibenclamide, 10238-21-8, Glybenclamide, Glynase, Diabeta, Micronase, Euglucon, Daonil, Glybenzcyclamide, Semi-daonil, Apo-Glibenclamide, Azuglucon, Bastiverit, Benclamin, Betanase, Duraglucon, Euglucan, Euglykon, Glibenil, Glucolon, Orabetic, Prodiabet, Renabetic, Yuglucon, Dibelet, Gilemal, Glibens, Glibil, Glimel, Glimide, Humedia, Libanil, Maninil, Suraben, Tiabet, Adiab, Melix, Pira, Med-Glionil, Euglucon 5, Glibenclamidum, Calabren, Euclamin, Gewaglucon, Glibenbeta, Glibesyn, Glibetic, Gliboral, Glidiabet, Glisulin, Glitisol, Glucobene, Glucohexal, Glucomid, Glucoremed, Glucoven, Glycomin, Hexaglucon, Lederglib, Lisaglucon, Miglucan, Normoglucon, Praeciglucon, Cytagon, Debtan, Glamide, Gliban, Gliben, Glibet, Glicem, Gluben, Glyben, Sugril, Nadib, Novo-Glyburide, Glibenclamid AL, Gen-Glybe, Norglicem 5, Betanese 5, Glibenclamid Fabra, Glibenclamida, Glibenclamid Basics, Glibenclamid-Cophar, Glibenclamid Heumann, Semi-Euglucon, Hemi-Daonil, Glibenclamid Genericon, Glibenclamid-Ratiopharm, 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide, Semi-Gliben-Puren N, Glibenclamid Riker M., HB 419, Glibenclamidum [INN-Latin], Glyburide (micronized), GBN 5, Glibenclamida [INN-Spanish], Micronized glyburide, UR 606, glyburide (glibenclamide), 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea, 1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea, HB-419, Amglidia, Cirara, UNII-SX6K58TVWC, U 26452, SX6K58TVWC, 5-Chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide, EINECS 233-570-6, NSC-759618, Neogluconin, BRN 2230085, CHEBI:5441, 5-chloro-N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-2-methoxybenzamide, Glibenclamide [INN], 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide, Glyburide [USAN:USP], N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea, Benzamide, 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-, Glubate, MFCD00056625, CHEMBL472, U-26452, RP-1127, 5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide, U-26,452, Urea, 1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexyl-, MLS000069721, DTXSID0037237, U-26,45, Urea, 1-((p-(2-(chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl-, GLUCOVANCE COMPONENT GLYBURIDE, Benzamide, 5-chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxy-, N-(4-(beta-(2-Methoxy-5-chlorbenzamido)-aethyl)-benzolsulfonyl)-N'-cyclohexyl-harnstoff, NSC 759618, Glyburide [USAN], NCGC00015467-11, Abbenclamide, Diabiphage, Glibadone, SMR000058229, Glyburide (USAN:USP), C23H28ClN3O5S, CAS-10238-21-8, N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea, GLYBURIDE (USP-RS), GLYBURIDE [USP-RS], Glibenclamidum (INN-Latin), 5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide, 5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]-amino]sulfonyl]phenyl]-ethyl]-2-methoxybenzamide, Glibenclamida (INN-Spanish), GLIBENCLAMIDE (MART.), GLIBENCLAMIDE [MART.], DTXCID8017237, GLYBURIDE (USP MONOGRAPH), GLYBURIDE [USP MONOGRAPH], Glycron, GLIBENCLAMIDE (EP MONOGRAPH), GLIBENCLAMIDE [EP MONOGRAPH], 1-[[p-[2-(5-Chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohexylurea, 5-chloro-N-(2-{4-[N-(N-cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide, Glyburide (USP), Micronase (TN), 1-{4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonyl}-3-cyclohexylurea;1-{4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonyl}-3-cyclohexylurea, Diabeta (TN), Glynase (TN), SR-01000000196, Delmide, 5-chloro-N-(2-(4-(N-(N-cyclohexylcarbamoyl)sulfamoyl)phenyl)ethyl)-2-methoxybenzamide, 5-chloro-N-(4-[N-(cyclohexylcarbamoyl)sulfamoyl]phenethyl)-2-methoxybenzamide, Glibenclamide,(S), GBM, Prestwick_569, Spectrum_000250, Tocris-0911, Glibenclamide - Bio-X, Glybenzcyclamide, 99%, Glibenclamide; Glyburide, Opera_ID_801, GLYBURIDE [MI], Prestwick0_000316, Prestwick1_000316, Prestwick2_000316, Prestwick3_000316, Spectrum2_001816, Spectrum3_001327, Spectrum4_001199, Spectrum5_001631, GLYBURIDE [VANDF], Lopac-G-0639, Probes1_000431, Probes2_000378, UPCMLD-DP006, G 0639, GLIBENCLAMIDE [JAN], GLYBURIDE [WHO-IP], Glibenclamide (JP17/INN), CBiol_001790, Lopac0_000499, Oprea1_764617, SCHEMBL22009, BSPBio_000312, BSPBio_001351, BSPBio_003053, KBioGR_000071, KBioGR_001897, KBioSS_000071, KBioSS_000730, MLS001077262, BIDD:GT0239, DivK1c_000481, SPECTRUM2300229, SPBio_001831, SPBio_002531, GLIBENCLAMIDE [WHO-DD], GLIBENCLAMIDE [WHO-IP], BPBio1_000344, GTPL2414, GLYBURIDE [ORANGE BOOK], UPCMLD-DP006:001, HMS501I03, KBio1_000481, KBio2_000071, KBio2_000730, KBio2_002639, KBio2_003298, KBio2_005207, KBio2_005866, KBio3_000141, KBio3_000142, KBio3_002273, A10BB01, Glybenclamide, >=99% (HPLC), NINDS_000481, Bio1_000076, Bio1_000565, Bio1_001054, Bio2_000071, Bio2_000551, HMS1361D13, HMS1568P14, HMS1791D13, HMS1922L08, HMS1989D13, HMS2089L06, HMS2093P04, HMS2095P14, HMS3259O12, HMS3261D19, HMS3267A15, HMS3402D13, HMS3411F16, HMS3428D15, HMS3651E17, HMS3675F16, HMS3712P14, Pharmakon1600-02300229, BCP05327, Glibenclamide for peak identification, Tox21_110158, Tox21_300758, Tox21_500499, BDBM50012957, CCG-39618, HD 419, NSC759618, NSC813214, STK362992, GLIBENCLAMIDUM [WHO-IP LATIN], Glyburide - CAS 10238-21-8, AKOS001487495, Tox21_110158_1, BCP9000729, CS-1075, DB01016, KS-5326, LP00499, NC00566, NSC-813214, SB17414, SDCCGSBI-0050483.P004, 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)-phenethyl)-2-methoxybenzamide, GLYBURIDE COMPONENT OF GLUCOVANCE, IDI1_000481, IDI1_033821, Glibenclamide 1.0 mg/ml in Acetonitrile, NCGC00015467-01, NCGC00015467-02, NCGC00015467-03, NCGC00015467-04, NCGC00015467-05, NCGC00015467-06, NCGC00015467-07, NCGC00015467-08, NCGC00015467-09, NCGC00015467-10, NCGC00015467-12, NCGC00015467-13, NCGC00015467-14, NCGC00015467-15, NCGC00015467-16, NCGC00015467-17, NCGC00015467-18, NCGC00015467-20, NCGC00015467-21, NCGC00015467-36, NCGC00015467-37, NCGC00016689-01, NCGC00023447-02, NCGC00023447-04, NCGC00023447-05, NCGC00023447-06, NCGC00023447-07, NCGC00023447-08, NCGC00023447-09, NCGC00023447-10, NCGC00023447-11, NCGC00023447-12, NCGC00254662-01, NCGC00261184-01, BG166164, HY-15206, SY057080, SBI-0050483.P003, Glyburide, meets USP testing specifications, AB00051949, EU-0100499, FT-0601608, G0382, NS00001144, S1716, SW195828-5, A19539, C07022, D00336, D81733, EN300-117270, M01823, AB00051949-16, AB00051949-17, AB00051949_18, AB00051949_19, Q420626, SR-01000000196-2, SR-01000000196-4, SR-01000000196-5, SR-01000000196-6, SR-01000000196-8, W-108874, BRD-K36927236-001-06-0, BRD-K36927236-001-17-7, Z277540138, Glybenclamide, European Pharmacopoeia (EP) Reference Standard, Glyburide, United States Pharmacopeia (USP) Reference Standard, 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl urea, 5-Chloro-N-[4-(3-cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide, 4-(2-(5-Chloro-2-methoxybenzoylamino)ethyl)-N-(cyclohexylcarbamoyl)benzenesulfonamide, Glibenclamide for peak identification, European Pharmacopoeia (EP) Reference Standard, Glyburide (Glibenclamide), Pharmaceutical Secondary Standard; Certified Reference Material, N-(4-(.beta.-(2-Methoxy-5-chlorbenzamido)-aethyl)-benzolsulfonyl)-N'-cyclohexyl-harnstoff, N1-[4-({[(cyclohexylamino)carbonyl]amino}sulfonyl)phenethyl]-5-chloro-2-methoxybenzamide, 5-Chloro-N-(2-[4-(([(cyclohexylamino)carbonyl]amino)sulfonyl)phenyl]ethyl)-2-methoxybenzamide #
Drug Type	Small molecule
Formula	C₂₃H₂₈ClN₃O₅S
SMILES	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
InChI	1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)
InChIKey	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
CAS Number	10238-21-8
ChEMBL ID	CHEMBL472
ChEBI ID	CHEBI:5441
TTD ID	D05LYX
Drug Bank ID	DB01016
KEGG ID	C07022
Toxicity	Organism	Test Type	Route(Dose)
	rat	LD50	intraperitoneal(165 mg/kg)
	mouse	LD50	intraperitoneal(254 mg/kg)
	rat	LD50	oral(322 mg/kg)
Structure			Download 2D MOL 3D MOL

Pair Name	Niacinamide, Glyburide
Partner Name	Niacinamide
Result	The efficacy of insulin and other antidiabetic agents may be diminished by certain drugs, including atypical antipsychotics, corticosteroids, diuretics, estrogens, gonadotropin-releasing hormone agonists, human growth hormone, phenothiazines, progestins, protease inhibitors, sympathomimetic amines, thyroid hormones, L-asparaginase, alpelisib, copanlisib, danazol, diazoxide, isoniazid, megestrol, omacetaxine, phenytoin, tagraxofusp, temsirolimus, as well as pharmacologic dosages of nicotinic acid and adrenocorticotropic agents. These drugs may interfere with blood glucose control because they can cause hyperglycemia, glucose intolerance, new-onset diabetes mellitus, and/or exacerbation of preexisting diabetes.